ArticleMultiple sclerosis journal - experimental, translational and clinical

Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients.

Auli Verkkoniemi-Ahola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.